Nurse Anesthetist - CR in Chehalis, WA Accepting Medicare

6 Nurse Anesthetist - CR nurses found. Showing 1 - 6

Karen Sue Nemjo, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632

Christopher M Whaley, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632    Fax: 360-748-3869

Nancy L Anderson, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632    Fax: 360-748-8632

Kevin P Burman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Avenue, Chehalis, WA 98532 Phone: 360-748-8632    Fax: 360-748-3869

Robert D Poaster, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632    Fax: 360-748-3869

Mr. Paul Kurtis Anderson, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632    Fax: 360-748-3869

News Archive

Researchers study potential of menstrual blood-derived stem cells for stroke therapy

The potential for stem cells derived from menstrual blood to benefit stroke sufferers will be jointly investigated by researchers at the University of South Florida, Cryo-Cell International, Inc., a global stem cell company based in Oldsmar, FL, and Saneron CCEL Therapeutics, Inc. a Tampa-based biotechnology company.

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the "RNA Silencing: Mechanism, Biology, and Application" Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam's therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington's disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

A better qPCR pipetting experience with VIAFLO electronic pipettes

INTEGRA Biosciences' VIAFLO electronic pipettes are making qPCR plate preparation the straightforward process it should be for researchers in the Saint-Geniez lab at Harvard Medical School.

New drug shows promise against lung cancer caused by genetic mutation

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.

Study identifies local traffic exhaust as a risk factor for stroke

High levels of traffic exhaust at one's residence increases the risk of stroke even in low-pollution environments, according to a study by researchers at Karolinska Institutet and other universities in Sweden.

Read more Medical News

› Verified 6 days ago